Xiamen Amoytop Biotech Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

2.53

Vol. 1Y

—

Shs. 5Y

0.25%

Rev. 5Y

36.01%

Div Yld LY

—

Div Yld TTM

—

Revenues

3.70b

+31.18%

Net income

1.03b

+24.61%

CFO

729m

+69.37%

Dividend

May 29, 20260.62 /sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Xiamen Amoytop Biotech Co., Ltd. specializes in the creation, commercialization, and distribution of biopharmaceutical products within China, utilizing advanced genetic engineering techniques. Its offerings span a variety of pharmaceutical goods, including finished drug formulations, diagnostic reagents, and active pharmaceutical ingredients (APIs). The company further extends its services to include bespoke contract manufacturing. Founded in 1996, the firm is headquartered in Xiamen, China.

URL

http://www.amoytop.com/

IPO date

Jan 17, 2020

Employees

Domiciled in

Incorporated in

Valuation

Latest on right Latest on left

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT